Cargando…

Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission

BACKGROUND: The characterization of HIV-1 transmission strains may inform the design of an effective vaccine. Shorter variable loops with fewer predicted glycosites have been suggested as signatures enriched in envelope sequences derived during acute HIV-1 infection. Specifically, a transmission-lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mota, Talia M, Murray, John M, Center, Rob J, Purcell, Damian F J, McCaw, James M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419081/
https://www.ncbi.nlm.nih.gov/pubmed/22731404
http://dx.doi.org/10.1186/1742-4690-9-54
_version_ 1782240679955529728
author Mota, Talia M
Murray, John M
Center, Rob J
Purcell, Damian F J
McCaw, James M
author_facet Mota, Talia M
Murray, John M
Center, Rob J
Purcell, Damian F J
McCaw, James M
author_sort Mota, Talia M
collection PubMed
description BACKGROUND: The characterization of HIV-1 transmission strains may inform the design of an effective vaccine. Shorter variable loops with fewer predicted glycosites have been suggested as signatures enriched in envelope sequences derived during acute HIV-1 infection. Specifically, a transmission-linked lack of glycosites within the V1 and V2 loops of gp120 provides greater access to an α4β7 binding motif, which promotes the establishment of infection. Also, a histidine at position 12 in the leader sequence of Env has been described as a transmission signature that is selected against during chronic infection. The purpose of this study is to measure the association of the presence of an α4β7 binding motif, the number of N-linked glycosites, the length of the variable loops, and the prevalence of histidine at position 12 with HIV-1 transmission. A case–control study design was used to measure the prevalence of these variables between subtype B and C transmission sequences and frequency-matched randomly-selected sequences derived from chronically infected controls. RESULTS: Subtype B transmission strains had shorter V3 regions than chronic strains (p = 0.031); subtype C transmission strains had shorter V1 loops than chronic strains (p = 0.047); subtype B transmission strains had more V3 loop glycosites (p = 0.024) than chronic strains. Further investigation showed that these statistically significant results were unlikely to be biologically meaningful. Also, there was no difference observed in the prevalence of a histidine at position 12 among transmission strains and controls of either subtype. CONCLUSIONS: Although a genetic bottleneck is observed after HIV-1 transmission, our results indicate that summary characteristics of Env hypothesised to be important in transmission are not divergent between transmission and chronic strains of either subtype. The success of a transmission strain to initiate infection may be a random event from the divergent pool of donor viral sequences. The characteristics explored through this study are important, but may not function as genotypic signatures of transmission as previously described.
format Online
Article
Text
id pubmed-3419081
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34190812012-08-15 Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission Mota, Talia M Murray, John M Center, Rob J Purcell, Damian F J McCaw, James M Retrovirology Research BACKGROUND: The characterization of HIV-1 transmission strains may inform the design of an effective vaccine. Shorter variable loops with fewer predicted glycosites have been suggested as signatures enriched in envelope sequences derived during acute HIV-1 infection. Specifically, a transmission-linked lack of glycosites within the V1 and V2 loops of gp120 provides greater access to an α4β7 binding motif, which promotes the establishment of infection. Also, a histidine at position 12 in the leader sequence of Env has been described as a transmission signature that is selected against during chronic infection. The purpose of this study is to measure the association of the presence of an α4β7 binding motif, the number of N-linked glycosites, the length of the variable loops, and the prevalence of histidine at position 12 with HIV-1 transmission. A case–control study design was used to measure the prevalence of these variables between subtype B and C transmission sequences and frequency-matched randomly-selected sequences derived from chronically infected controls. RESULTS: Subtype B transmission strains had shorter V3 regions than chronic strains (p = 0.031); subtype C transmission strains had shorter V1 loops than chronic strains (p = 0.047); subtype B transmission strains had more V3 loop glycosites (p = 0.024) than chronic strains. Further investigation showed that these statistically significant results were unlikely to be biologically meaningful. Also, there was no difference observed in the prevalence of a histidine at position 12 among transmission strains and controls of either subtype. CONCLUSIONS: Although a genetic bottleneck is observed after HIV-1 transmission, our results indicate that summary characteristics of Env hypothesised to be important in transmission are not divergent between transmission and chronic strains of either subtype. The success of a transmission strain to initiate infection may be a random event from the divergent pool of donor viral sequences. The characteristics explored through this study are important, but may not function as genotypic signatures of transmission as previously described. BioMed Central 2012-06-25 /pmc/articles/PMC3419081/ /pubmed/22731404 http://dx.doi.org/10.1186/1742-4690-9-54 Text en Copyright ©2012 Mota et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mota, Talia M
Murray, John M
Center, Rob J
Purcell, Damian F J
McCaw, James M
Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission
title Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission
title_full Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission
title_fullStr Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission
title_full_unstemmed Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission
title_short Application of a case–control study design to investigate genotypic signatures of HIV-1 transmission
title_sort application of a case–control study design to investigate genotypic signatures of hiv-1 transmission
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419081/
https://www.ncbi.nlm.nih.gov/pubmed/22731404
http://dx.doi.org/10.1186/1742-4690-9-54
work_keys_str_mv AT motataliam applicationofacasecontrolstudydesigntoinvestigategenotypicsignaturesofhiv1transmission
AT murrayjohnm applicationofacasecontrolstudydesigntoinvestigategenotypicsignaturesofhiv1transmission
AT centerrobj applicationofacasecontrolstudydesigntoinvestigategenotypicsignaturesofhiv1transmission
AT purcelldamianfj applicationofacasecontrolstudydesigntoinvestigategenotypicsignaturesofhiv1transmission
AT mccawjamesm applicationofacasecontrolstudydesigntoinvestigategenotypicsignaturesofhiv1transmission